BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

  June 23, 2025

   · 

  10 min read
• Press Releases

  Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress

  June 23, 2025

   · 

  9 min read
• Press Releases

  Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

  June 23, 2025

   · 

  4 min read
• Press Releases

  Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A

  June 23, 2025

   · 

  8 min read
• Press Releases

  Idorsia’s QUVIVIQ expands into China as Simcere receives NDA approval – Idorsia and Simcere update their licensing agreement

  June 23, 2025

   · 

  4 min read
• Press Releases

  AB Science - New peer-reviewed data provide strong evidence supporting masitinib potential for the treatment of Alzheimer’s disease

  June 23, 2025

   · 

  9 min read
• Press Releases

  Cell Study by SDU and PKU Researchers Reveals Novel Mechanism to Regulate Glucose Metabolism

  June 23, 2025

   · 

  1 min read
• Press Releases

  Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)

  June 23, 2025

   · 

  11 min read
• Press Releases

  Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

  June 23, 2025

   · 

  9 min read
• Press Releases

  Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)

  June 23, 2025

   · 

  10 min read